Adjuvant Treatment Deintensification for HPV-Associated Oropharyngeal Cancer
Posted: 04/01/2024 | By: Chase Doyle

A nonrandomized, multi-arm phase II trial—results of which were presented by Thorstad et al at the 2024 Multidisciplinary Head and Neck Cancer—assessed the efficacy of two de-escalated adjuvant therapy regimens in patients with surgically resected locally advanced, human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma.

Question 1 of 5

What was the primary objective of the Minimally Invasive Minimum Therapy (MINT) trial?

Choose 1